Macular Thickness | Duration | Alzer-Diamel Average ± SEM n = 25 | Placebo Average ± SEM n = 24 | P-Value |
MT LE | Start | 189.28 ± 10.26 | 181.48 ± 13.20 | 0.331 |
12 months | 178.94 ± 8.74 | 199.52 ± 13.30 | 0.291 | |
Change | −10.33 ± 11.99 | 18.05 ± 8.94 | 0.016 | |
MT RE | Start | 184.06 ± 11.76 | 184.65 ± 14.16 | 0.610 |
12 months | 171.81 ± 10.47 | 210.63 ± 14.96 | 0.066 | |
Change | −13.07 ± 12.64 | 15.45 ± 13.26 | 0.463 | |
VA LE | Start | 0.95 ± 0.03 | 0.93 ± 0.03 | 0.300 |
12 months | 0.94 ± 0.04 | 0.092 ± 0.03 | 0.153 | |
Change | −0.008 ± 0.03 | −0.013 ± 0.016 | 0.988 | |
VA RE | Start | 0.97 ± 0.03 | 0.95 ± 0.04 | 0.532 |
12 months | 0.97 ± 0.02 | 0.95 ± 0.04 | 0.966 | |
Change | −0.004 ± 0.015 | −0.008 ± 0.006 | 0.333 |